Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 278

1.

Increased level of von Willebrand factor is significantly and independently associated with diabetes in postinfarction patients. THROMBO Investigators.

Zareba W, Pancio G, Moss AJ, Kalaria VG, Marder VJ, Weiss HJ, Watelet LF, Sparks CE.

Thromb Haemost. 2001 Sep;86(3):791-9.

PMID:
11583309
[PubMed - indexed for MEDLINE]
2.

Gender-related differences in thrombogenic factors predicting recurrent cardiac events in patients after acute myocardial infarction. The THROMBO Investigators.

Kalaria VG, Zareba W, Moss AJ, Pancio G, Marder VJ, Morrissey JH, Weiss HJ, Sparks CE, Greenberg H, Dwyer E, Goldstein R, Watelet LF.

Am J Cardiol. 2000 Jun 15;85(12):1401-8.

PMID:
10856383
[PubMed - indexed for MEDLINE]
3.

Thrombogenic factors and recurrent coronary events.

Moss AJ, Goldstein RE, Marder VJ, Sparks CE, Oakes D, Greenberg H, Weiss HJ, Zareba W, Brown MW, Liang CS, Lichstein E, Little WC, Gillespie JA, Van Voorhees L, Krone RJ, Bodenheimer MM, Hochman J, Dwyer EM Jr, Arora R, Marcus FI, Watelet LF, Case RB.

Circulation. 1999 May 18;99(19):2517-22.

PMID:
10330382
[PubMed - indexed for MEDLINE]
Free Article
4.

Tissue factor pathway inhibitor and other endothelium-dependent hemostatic factors in elderly individuals with normal or impaired glucose tolerance and type 2 diabetes.

Leurs PB, Stolk RP, Hamulyak K, Van Oerle R, Grobbee DE, Wolffenbuttel BH.

Diabetes Care. 2002 Aug;25(8):1340-5.

PMID:
12145232
[PubMed - indexed for MEDLINE]
5.

History of hypertension and enhanced thrombogenic activity in postinfarction patients.

Fadl YY, Zareba W, Moss AJ, Marder VJ, Sparks CS, Miller Watelet LF, Carroll ER.

Hypertension. 2003 Apr;41(4):943-9. Epub 2003 Mar 10.

PMID:
12629034
[PubMed - indexed for MEDLINE]
Free Article
6.

Aortic endothelial cell von Willebrand factor content, and circulating plasminogen activator inhibitor-1 are increased, but expression of endothelial leukocyte adhesion molecules is unchanged in insulin-dependent diabetic BB rats.

Ribau JC, Samis JA, Senis YA, Maurice DH, Giles AR, DeReske M, Absher PM, Hatton MW, Richardson M.

Atherosclerosis. 2000 Apr;149(2):331-42.

PMID:
10729383
[PubMed - indexed for MEDLINE]
7.

PAI-1 activity, but not fibrinogen or von Willebrand factor, is inversely related to LDL particle size in type 2 diabetes.

Mertens I, Lemieux I, Verrijken A, Després JP, Van Gaal LF.

Diabetes Metab Res Rev. 2008 Feb;24(2):141-7.

PMID:
17922472
[PubMed - indexed for MEDLINE]
8.

Improvement of glycaemic control in type 2 diabetes: favourable changes in blood pressure, total cholesterol and triglycerides, but not in HDL cholesterol, fibrinogen, Von Willebrand factor and (pro)insulin.

Becker A, van der Does FE, van Hinsbergh VW, Heine RJ, Bouter LM, Stehouwer CD.

Neth J Med. 2003 Apr;61(4):129-36.

PMID:
12852722
[PubMed - indexed for MEDLINE]
Free Article
9.

Effects of lipids and lipid-lowering therapy on hemostatic factors in patients with myocardial infarction.

Kaba NK, Francis CW, Moss AJ, Zareba W, Oakes D, Knox KL, Fernández ID, Rainwater DL; THROMBO Investigators.

J Thromb Haemost. 2004 May;2(5):718-25.

PMID:
15099276
[PubMed - indexed for MEDLINE]
10.
11.

Hyperglycaemic siblings of Type II (non-insulin-dependent) diabetic patients have increased PAI-1, central obesity and insulin resistance compared with their paired normoglycaemic sibling.

Herlihy OM, Barrow BA, Grant PJ, Levy JC.

Diabetologia. 2002 May;45(5):635-41. Epub 2002 Apr 26.

PMID:
12107743
[PubMed - indexed for MEDLINE]
12.

In patients with deep-vein thrombosis elevated levels of factor VIII correlate only with von Willebrand factor but not other endothelial cell-derived coagulation and fibrinolysis proteins.

Bombeli T, Jutzi M, De Conno E, Seifert B, Fehr J.

Blood Coagul Fibrinolysis. 2002 Oct;13(7):577-81.

PMID:
12439142
[PubMed - indexed for MEDLINE]
13.

Impaired endothelial antithrombotic activity following short-term interruption of continuous subcutaneous insulin infusion in type 1 diabetic patients.

Iorio A, Federici MO, Mourvaki E, Ferolla P, Piroddi M, Stabile A, Timi A, Celleno R, Benedetti MM.

Thromb Haemost. 2007 Sep;98(3):635-41.

PMID:
17849053
[PubMed - indexed for MEDLINE]
15.

Interactions between fibrinolysis, lipoproteins and leptin related to a first myocardial infarction.

Thøgersen AM, Söderberg S, Jansson JH, Dahlén G, Boman K, Nilsson TK, Lindahl B, Weinehall L, Stenlund H, Lundberg V, Johnson O, Ahrén B, Hallmans G.

Eur J Cardiovasc Prev Rehabil. 2004 Feb;11(1):33-40.

PMID:
15167204
[PubMed - indexed for MEDLINE]
16.

Effect of smoking on lipid and thrombogenic factors two months after acute myocardial infarction.

Fisher SD, Zareba W, Moss AJ, Marder VJ, Sparks CE, Hochman J, Liang C, Krone RJ; THROMBO Investigators.

Am J Cardiol. 2000 Oct 15;86(8):813-8.

PMID:
11024393
[PubMed - indexed for MEDLINE]
17.

Insulin resistance and endothelial dysfunction in type 2 diabetes patients with or without microalbuminuria.

Yu Y, Suo L, Yu H, Wang C, Tang H.

Diabetes Res Clin Pract. 2004 Aug;65(2):95-104.

PMID:
15223221
[PubMed - indexed for MEDLINE]
18.

von Willebrand factor (vWf) as a plasma marker of endothelial activation in diabetes: improved reliability with parallel determination of the vWf propeptide (vWf:AgII).

Vischer UM, Emeis JJ, Bilo HJ, Stehouwer CD, Thomsen C, Rasmussen O, Hermansen K, Wollheim CB, Ingerslev J.

Thromb Haemost. 1998 Dec;80(6):1002-7.

PMID:
9869174
[PubMed - indexed for MEDLINE]
19.
20.

Activation of tissue factor-induced coagulation and endothelial cell dysfunction in non-insulin-dependent diabetic patients with microalbuminuria.

Kario K, Matsuo T, Kobayashi H, Matsuo M, Sakata T, Miyata T.

Arterioscler Thromb Vasc Biol. 1995 Aug;15(8):1114-20.

PMID:
7627704
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk